PDCD1 and neoplasm: Another study reported extensive screening of a SMI, designated as PDI-1 (3) and reported to display significant anti-tumor potential through reduction of the PD-1/PD-L1-induced T-cell exhaustion in both in vitro as well as in vivo settings.